Akèy › Kansè (tout kalite) › Michigan › Ann Arbor
Etid klinik pou Kansè (tout kalite) nan Ann Arbor, MI
25 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of ASP3082 in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
- Trinity Health Ann Arbor Hospital, Ypsilanti · 7 mi lwen
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Ap rekriteEtid obsèvasyon
- University of Michigan, Ann Arbor
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Ap rekriteFaz 1
- University of Michigan, Ann Arbor
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Ap rekriteFaz 3
- University of Michigan Health System, Ann Arbor
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Ap rekriteFaz 3
- Quetzal Site 22, Ann Arbor
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Ap rekriteFaz 2
- Trinity Health Ann Arbor Hospital, Ann Arbor
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- University Of Michigan Comprehensive Cancer Center, Ann Arbor
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
- University of Michigan, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Ap rekriteFaz 1/2
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Ap rekriteFaz 1
- University of Michigan, Ann Arbor
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- University of Michigan, Ann Arbor
Prostate Active Surveillance Study
Ap rekriteEtid obsèvasyon
- University of Michigan, Ann Arbor
Lurbinectedin in FET-Fused Tumors
Ap rekriteFaz 1/2
- University of Michigan, Ann Arbor
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- C S Mott Children's Hospital, Ann Arbor
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Ap rekriteFaz 3
- University of Michigan, Ann Arbor
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Ap rekriteFaz 2
- C.S. Mott Children's Hospital, Ann Arbor
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi lwen
- ak 6 plis
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Ap rekriteFaz 2
- University of Michigan Health System - Ann Arbor /ID# 273511, Ann Arbor
Childhood Cancer Survivor Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Michigan/Mott Children's Hospital, Ann Arbor
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Ap rekrite
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Ap rekriteFaz 1
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Ap rekriteFaz 2
- Kellogg Eye Center, Ann Arbor
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Ap rekrite
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Ann Arbor
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Ap rekrite
- University of Michigan Medical Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi lwen
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA85 etid
- Los Angeles, CA74 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC58 etid
- Durham, NC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
Lòt etid nan Ann Arbor
- Kansè nan tete27 etid
- Kansè pwostat27 etid
- Kansè Poumon ki pa ti selil26 etid
- Kansè poumon23 etid
- Kansè kolorektal23 etid
- Ensifizyans kadyak22 etid
- Leksemi mieloïd egi17 etid
- Maladi kadyovaskilè16 etid
- Kansè pankreyas14 etid
- Melanom12 etid
- Akidan serebavaskilè12 etid
- Karsinòm selil skuamèz tèt ak kou12 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.